학술논문

Real-world outcomes of nivolumab plus ipilimumab combination therapy for advanced renal cell carcinoma in Japanese patients: data with a minimum of 3 years of follow-up
Document Type
Article
Source
In: Japanese Journal of Clinical Oncology. (Japanese Journal of Clinical Oncology, 1 May 2024, 54(5):577-583)
Subject
Language
English
ISSN
14653621
03682811